Nichol Ochsner | executive |
Neil McFarlane | executive |
R. Clifton | executive |
Louise Chen | analyst |
Joshua Schafer | executive |
Christal M. Mickle | executive |
Jonathan Aschoff | analyst |
Sumant Kulkarni | analyst |
Oren Livnat | analyst |
Good morning, everyone. Thank you for joining the Zevra Therapeutics Third Quarter 2023 Corporate Updates and Financial Results Call. Today's call is being recorded and will be made available on the company's website following the conclusion of the call.
With that, I will now turn the call over to Nichol Ochsner, Vice President of Investor Relations and Corporate Communications for Zevra Therapeutics. Please go ahead.